Eye drops could keep Kids' vision from getting worse
NCT ID NCT07626892
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested three low doses of atropine eye drops (0.01%, 0.03%, and 0.05%) in 95 children aged 6–18 with nearsightedness. The goal was to see which dose best slowed the worsening of myopia with the fewest side effects. Over 18 months, the 0.05% dose worked best at controlling vision changes, while all doses were generally well-tolerated.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atropine eye drops (low concentrations 0.01%, 0.03%, 0.05%)
- What this could lead to
- If confirmed, this could give doctors a safe, effective way to slow worsening nearsightedness in children, reducing their risk of serious eye problems later in life.
- What could go wrong
- This was a small, single-country study. The results may not apply to all children, and long-term safety beyond 18 months is not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Khyber Teaching Hospital
Peshawar, KPK, 25000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new lens design might stop adult nearsightedness from worsening
- Special lenses may curb worsening nearsightedness in kids
- Could special glasses stop nearsightedness from getting worse?
- New glasses film aims to stop kids' eyesight from getting worse
- New glasses for nearsighted kids put to the test
- New lenses may reveal how to slow nearsightedness in kids